Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2017-06-30
Product name
Idarubicin Hydrochloride Injection, USP
Chemical name
(1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl 3- amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside, hydrochloride
1.2.1 Relevant identified uses
Antineoplastic Anthracycline effective in treatment of some cancers such as acute leukemia, non-Hodgkin lymphomas, breast cancer, Hodgkin"s disease, and sarcomas
supplier name
West-Ward Pharmaceuticals Corp
Manufacturer Name
THYMOORGAN PHARMAZIE GmbH
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
THYMOORGAN PHARMAZIE GmbH
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H360
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
Signal word
Danger
Hazard statements
H360 - May damage fertility or the unborn child. H351 - Suspected of causing cancer. This is a pharmaceutical product designed to be prescribed by a licensed health care professional. Should any person while using this product observe any adverse health effects, they should seek medical treatment.
Prevention
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves. Wear eye or face protection. Wear protective clothing.
Response
P308 + P313 - IF exposed or concerned: Get medical attention.
Storage
P405 - Store locked up.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
2.3 Other hazards
None known.
2.1 Classification of the substance or mixture
Classification of the : CARCINOGENICITY - Category 2 substance or mixture TOXIC TO REPRODUCTION (Fertility) - Category 1B TOXIC TO REPRODUCTION (Unborn child) - Category 1B
